| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), COEP's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Desilva Tara | Director | Buy | 2,266 | $0.58 | $1,304.96 | +7.6% | -29.5% | -38.0% | |
| Jan 10, 2024 | Cogley Brian | Chief Financial Officer | Buy | 5,000 | $0.67 | $3,350.00 | +20.0% | -43.6% | -45.1% | |
| Jan 8, 2024 | Mehalick David | CEO And President | Buy | 25,054 | $0.67 | $16,747.14 | +0.9% | -47.7% | -49.6% | |
| Jan 5, 2024 | Yerace Daniel Alexander | VP Of Operations | Buy | 10,850 | $0.69 | $7,486.50 | +1.0% | -52.4% | -58.7% | |
| Jan 5, 2024 | Cochran Christopher P. | Director | Buy | 7,000 | $0.77 | $5,390.00 | +23.3% | -52.4% | -58.7% | |
| Jan 5, 2024 | Salkind Gene | Director | Buy | 11,600 | $0.69 | $8,004.00 | +4.3% | -52.4% | -58.7% | |
| Aug 29, 2023 | Salkind Gene | - | Buy | 32,644 | $0.92 | $30,106.64 | -114.1% | +8.4% | -81.8% | |
| Aug 23, 2023 | Calise Chris | - | Buy | 11,582 | $0.94 | $10,878.56 | +0.8% | +31.5% | -77.0% | |
| May 4, 2022 | Harraden Circle Investments, LLC78 | 10% Owner | Sell | 85,305 | $10.11 | $862,433.55 | -16.6% | +0.4% | -87.6% | |
| May 26, 2021 | Glazer Capital, LLC69 | 10% Owner | Sell | 56,118 | $9.85 | $552,762.30 | -5.5% | +0.1% | +1.9% |